Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23618,1368,1.16 [1.10-1.23],2.500695973873907e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,23739,1376,1.55 [1.41-1.69],2.754263170267733e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,23992,1371,2.32 [1.95-2.75],4.721552868171149e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,24200,1394,1.28 [1.19-1.38],1.0388636380301344e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20528,1188,1.34 [1.22-1.48],4.2912760265561055e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,21122,1217,1.87 [1.58-2.21],1.3930563690189174e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,20675,1203,1.38 [1.19-1.60],1.7205903034528125e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,24101,1383,1.19 [1.10-1.28],1.6149712222120504e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,24200,1394,0.68 [0.57-0.81],1.2060168200268324e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,23739,1376,1.12 [1.06-1.18],7.93107732199571e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,24400,1401,2.15 [1.80-2.58],7.560908821951642e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,23416,1343,1.16 [1.11-1.22],2.3522813769201354e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,23576,1366,1.23 [1.14-1.33],3.1439393312123146e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,24314,1410,1.62 [1.43-1.84],4.6553014646523477e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,24435,1413,1.21 [1.11-1.33],2.0175192971091505e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,24200,1394,1.13 [1.06-1.20],7.576996440818341e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24108,1395,1.30 [1.23-1.37],1.5285394225647432e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",24101,1383,1.40 [1.34-1.46],2.792822708155567e-56
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,24365,1399,1.87 [1.48-2.37],2.221051201167483e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,24400,1401,1.48 [1.32-1.67],5.885608681517681e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,23615,1355,1.18 [1.12-1.25],9.179812226822255e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,24200,1394,0.76 [0.69-0.83],3.649175153600969e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,24101,1383,1.40 [1.28-1.53],1.2831427402161336e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,24033,1375,2.19 [1.89-2.55],5.38708291624386e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,21143,1218,1.68 [1.38-2.03],1.504239626220823e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20595,1191,1.37 [1.18-1.60],4.999158315068169e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",24314,1410,1.43 [1.21-1.70],2.941755873259045e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23618,1368,1.26 [1.17-1.35],8.38086036939785e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,24033,1375,0.59 [0.51-0.68],1.1792853486216962e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,20675,1203,1.93 [1.66-2.25],2.1176183298501186e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,24126,1399,1.19 [1.10-1.29],2.1309668080289497e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,24392,1408,1.85 [1.46-2.33],2.498260206394095e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,24408,1403,1.25 [1.16-1.34],6.5948136343341875e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,24314,1410,1.45 [1.22-1.74],3.336831918148206e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,24143,1396,1.32 [1.17-1.48],2.413786844467597e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,24400,1401,0.71 [0.62-0.82],1.1567059722535648e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,24485,1416,1.56 [1.29-1.89],6.330828216021847e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",23739,1376,1.13 [1.07-1.19],3.1600446563310137e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,24117,1394,0.82 [0.77-0.89],4.036438829727982e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,23984,1373,1.17 [1.08-1.26],5.57382538128882e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,24137,1388,1.69 [1.34-2.13],8.600285942114629e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,24400,1401,0.62 [0.53-0.72],1.6612718790161566e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,24200,1394,1.39 [1.21-1.59],2.317726889972037e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,24485,1416,1.29 [1.17-1.42],6.61533828338097e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,24485,1416,1.26 [1.15-1.39],1.015217264153002e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,24166,1400,1.18 [1.12-1.24],1.7172462307357308e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,24435,1413,1.16 [1.10-1.21],4.257999470410115e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,24314,1410,1.22 [1.10-1.34],7.046724863284478e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,23981,1394,1.29 [1.18-1.40],7.902110544114269e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,24314,1410,1.29 [1.15-1.44],9.6988442897284e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,24435,1413,1.23 [1.12-1.35],2.2243991029568387e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,24200,1394,1.19 [1.10-1.29],2.6718871635436487e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,24072,1392,1.19 [1.10-1.28],5.09420956922602e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,24143,1396,1.20 [1.13-1.28],6.232231260876317e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,24267,1406,1.10 [1.05-1.15],5.0588756713643024e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,24143,1396,1.32 [1.24-1.41],5.3862212502760666e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,24056,1380,1.16 [1.09-1.23],1.960581298961151e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,24451,1416,1.40 [1.22-1.61],1.7917171719000338e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,23655,1370,1.40 [1.25-1.57],2.892488617281125e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,21122,1217,0.75 [0.66-0.86],3.840474900892241e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,24272,1406,1.35 [1.20-1.51],2.258440289479073e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,24033,1375,1.45 [1.28-1.66],1.6547858944265783e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,24314,1395,1.42 [1.27-1.59],1.1466212950202095e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,24101,1383,1.75 [1.51-2.03],1.1113875480192831e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,24323,1401,0.68 [0.56-0.82],8.557166398141473e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,24107,1393,1.55 [1.41-1.71],2.8038914623531614e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,24018,1387,1.41 [1.22-1.64],3.631260394479967e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,24365,1399,1.54 [1.35-1.75],4.395046285490122e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,23272,1327,1.60 [1.31-1.96],5.974994481312544e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,24408,1403,1.32 [1.16-1.51],4.162570801046334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,24143,1396,1.78 [1.57-2.02],2.974378128716016e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,24192,1398,1.59 [1.31-1.92],1.8977666726872267e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,24033,1375,1.66 [1.52-1.81],1.790949267349952e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21010,1209,0.84 [0.79-0.90],1.1136341898435158e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23317,1345,1.44 [1.36-1.53],1.5722968226456983e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21122,1217,1.99 [1.72-2.29],2.0439461253022565e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,23739,1376,1.20 [1.10-1.31],6.181732008366115e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,24101,1383,1.19 [1.10-1.28],2.657122817372548e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,21172,1227,2.01 [1.54-2.64],3.752460654939589e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,24200,1394,1.36 [1.22-1.52],3.024697936790205e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21076,1210,1.76 [1.57-1.98],8.331650575803886e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,21007,1211,1.60 [1.37-1.86],2.3620697808949004e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,21122,1217,1.24 [1.18-1.31],5.364141138824703e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,23625,1365,1.40 [1.33-1.48],8.452048857488942e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,21122,1217,1.26 [1.14-1.39],6.65794386993456e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,24316,1403,1.94 [1.67-2.26],2.189594641469514e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,24033,1375,1.32 [1.16-1.52],4.3767699982539776e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,20660,1195,0.52 [0.40-0.68],1.210696376822784e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,24143,1396,0.71 [0.62-0.81],2.728117478812995e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,24143,1396,1.33 [1.24-1.43],5.729328843551927e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,24124,1390,1.59 [1.36-1.86],3.600795943030534e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,23618,1368,1.23 [1.12-1.36],4.081825437304243e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,24400,1401,1.63 [1.29-2.06],4.752087497553779e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,24164,1393,0.79 [0.71-0.87],7.011022770828655e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,24485,1416,0.59 [0.50-0.71],9.0076854349356e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,24246,1393,0.77 [0.67-0.87],5.178326859638521e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,24286,1408,1.97 [1.61-2.41],5.7427150886385185e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,24485,1416,1.66 [1.46-1.88],1.5776085910213014e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,24201,1404,1.79 [1.50-2.14],2.0601603930222072e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,24295,1398,1.42 [1.24-1.63],4.605418733719873e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,20675,1203,1.45 [1.25-1.68],6.201044468176746e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,24033,1375,1.32 [1.17-1.49],9.235398216843666e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,24400,1401,0.82 [0.76-0.88],4.9401050494317333e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,24314,1410,1.53 [1.30-1.80],3.9532093995880666e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,24233,1405,1.85 [1.59-2.15],1.0394909566099118e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,23836,1382,1.42 [1.27-1.59],3.90413499154342e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,21076,1210,0.84 [0.77-0.91],2.7269660237671985e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,22576,1303,1.79 [1.64-1.95],1.5445406934010866e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,24200,1394,1.85 [1.55-2.21],2.1309767215688446e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,24179,1400,1.46 [1.26-1.69],3.236203868143597e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,24143,1396,1.28 [1.18-1.38],6.247834919111619e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,24443,1415,1.91 [1.56-2.33],2.0303111520696806e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,24435,1413,2.78 [2.55-3.03],6.540870306358869e-123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,23995,1387,1.15 [1.08-1.23],1.3680952052875571e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,24314,1410,1.17 [1.10-1.26],2.163947014663175e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24101,1383,1.31 [1.19-1.45],6.062688820949484e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,23882,1373,1.08 [1.05-1.12],2.600164141592518e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,20595,1191,0.83 [0.76-0.90],1.4635855968678817e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,24143,1396,1.49 [1.33-1.68],1.8299310208447983e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,24101,1383,0.58 [0.51-0.67],3.1398629265891025e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,23997,1381,1.19 [1.10-1.29],2.5771744793068468e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,24318,1397,1.18 [1.10-1.27],5.398107714674243e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,20971,1211,1.30 [1.15-1.46],2.180566152871358e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21125,1219,1.15 [1.08-1.24],6.13190385680819e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,24400,1401,1.51 [1.33-1.71],1.2604106401587856e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,23739,1376,1.44 [1.27-1.64],1.672966167384856e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,20595,1191,1.88 [1.56-2.26],2.5434408395566585e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21010,1209,1.60 [1.34-1.90],1.7446117591772077e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,24154,1398,1.75 [1.49-2.06],1.3992699180475231e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,23992,1371,1.67 [1.44-1.94],2.3564306150338598e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,23618,1368,1.29 [1.16-1.44],5.547490457154625e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,24485,1416,0.44 [0.33-0.58],9.908188246678358e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,24143,1396,1.20 [1.12-1.29],2.2673408729732285e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,21125,1219,1.56 [1.35-1.81],3.272765352643488e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23439,1354,1.13 [1.07-1.19],6.937236656660331e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,23364,1338,1.49 [1.29-1.72],7.558930531349107e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,24485,1416,1.48 [1.25-1.76],8.051807809115835e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,20595,1191,1.16 [1.08-1.24],1.5601565880946162e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,24408,1403,1.50 [1.24-1.81],2.5789051120134283e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,24226,1403,2.31 [1.78-3.01],3.978119516585627e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",24201,1404,1.21 [1.16-1.27],2.2329383253289533e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",24200,1394,1.13 [1.07-1.19],8.225700357166399e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",21125,1219,1.45 [1.31-1.61],3.923327158117741e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",24485,1416,1.34 [1.22-1.48],4.617665418394763e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,21125,1219,1.94 [1.66-2.27],1.4035388371404312e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,24101,1383,1.36 [1.18-1.56],1.4793648115156094e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,24160,1391,1.51 [1.29-1.77],3.0562819479071577e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,21101,1217,1.24 [1.11-1.37],6.750719541573562e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,24361,1398,1.21 [1.16-1.25],6.829848211908798e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,24367,1400,1.28 [1.20-1.36],1.2172505446902631e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,24272,1406,0.74 [0.64-0.85],4.8781025952729385e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,24272,1406,1.63 [1.33-2.01],3.955162355514938e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,21143,1218,1.28 [1.18-1.39],8.797740753354672e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,20595,1191,1.97 [1.54-2.51],5.5617088905468224e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,24162,1396,1.92 [1.67-2.20],5.501274084291865e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,20675,1203,1.26 [1.16-1.38],1.5379299513004924e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,24272,1406,1.43 [1.25-1.64],2.6995550634213336e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24408,1403,1.30 [1.18-1.43],2.600878830395031e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,24314,1410,0.82 [0.76-0.89],2.922750429883288e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24101,1383,1.64 [1.41-1.92],5.478552195304797e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,21076,1210,1.20 [1.16-1.25],3.3428338535406333e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,23618,1368,1.11 [1.07-1.16],2.206398019497249e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20197,1172,1.49 [1.39-1.60],1.478401235489561e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,24485,1416,2.07 [2.00-2.14],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,23618,1368,1.19 [1.11-1.28],2.586487569219962e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,24361,1398,1.77 [1.51-2.09],4.323594379589488e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,24154,1398,1.37 [1.26-1.50],8.652806746426381e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,21076,1210,1.45 [1.21-1.73],5.655928379020236e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,20634,1200,1.57 [1.35-1.81],2.063814340810039e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,24033,1375,1.27 [1.14-1.43],2.615414700634717e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,23739,1376,1.18 [1.09-1.28],3.7036965034736586e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,20600,1184,1.33 [1.21-1.47],1.7160602079111924e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,21007,1211,1.28 [1.16-1.42],1.376508559836843e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,23739,1376,1.24 [1.15-1.33],5.358389853228213e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,21007,1211,1.26 [1.16-1.37],2.2596915089042244e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",24101,1383,1.27 [1.18-1.36],1.6294446124336348e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,21074,1209,0.46 [0.37-0.59],1.6972120884162942e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,24299,1407,1.19 [1.11-1.28],4.395106819722929e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,24400,1401,1.09 [1.05-1.12],2.2672159002194973e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,24365,1399,1.41 [1.32-1.52],1.683013252619715e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,24192,1398,1.68 [1.47-1.92],3.081195960825839e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,24435,1413,1.75 [1.54-1.99],1.1003925851973864e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,21038,1209,1.26 [1.14-1.38],2.575539675467102e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24143,1396,1.38 [1.17-1.62],9.621372917937072e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,23618,1368,0.68 [0.60-0.78],9.970677021457494e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23981,1386,1.57 [1.32-1.87],3.976584918660482e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,24070,1391,1.69 [1.47-1.94],1.1120606410002621e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,24200,1394,1.42 [1.28-1.58],2.599079966541108e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,24400,1401,1.27 [1.14-1.41],7.645916718508862e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20486,1177,1.84 [1.63-2.08],4.250742977656921e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,23867,1376,1.89 [1.73-2.06],3.025488742510724e-45
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,24485,1416,1.48 [1.26-1.73],1.2510202693227294e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24200,1394,1.62 [1.42-1.85],1.4156560929085154e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,24200,1394,1.55 [1.33-1.81],2.2841750021826563e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,21125,1219,1.21 [1.13-1.29],6.066339602203266e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,24314,1410,1.63 [1.39-1.91],2.2788329269311476e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,24143,1396,1.68 [1.47-1.91],7.483715837086533e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,24122,1403,1.25 [1.14-1.38],3.7701870724298167e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,24267,1406,1.48 [1.28-1.72],2.0446980356498376e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,23595,1358,1.16 [1.09-1.25],1.373889503340132e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,24159,1403,1.25 [1.16-1.34],3.407390416862991e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,21007,1211,1.19 [1.11-1.28],2.571472962022028e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,24006,1384,1.44 [1.27-1.62],2.4516639889304923e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,24143,1396,1.44 [1.28-1.63],2.700901637258e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,24101,1383,1.29 [1.23-1.34],8.002509961779283e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,24192,1398,0.80 [0.74-0.87],1.550079620712614e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,21007,1211,1.43 [1.31-1.57],3.2773736738026707e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,20675,1203,1.32 [1.19-1.46],2.678895711180017e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20595,1191,1.22 [1.11-1.34],2.7314433012669835e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,24143,1396,0.72 [0.63-0.82],1.7296320306979472e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,24192,1398,0.69 [0.59-0.81],4.015196235705333e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,24400,1401,0.44 [0.33-0.58],1.0010478577364755e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,20595,1191,1.22 [1.12-1.34],6.693150468204153e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,24200,1394,0.69 [0.61-0.77],3.5532261611377536e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,20435,1186,1.34 [1.18-1.52],3.1661642940919333e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,23688,1351,1.27 [1.14-1.40],9.259885836221456e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",24101,1383,1.18 [1.12-1.25],3.2453508631869282e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",24108,1395,1.18 [1.10-1.26],1.6013744906493075e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",20435,1186,1.19 [1.11-1.26],1.1093806252066537e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,24435,1413,1.26 [1.14-1.39],5.890419905164308e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24201,1404,1.42 [1.27-1.59],7.205466006039095e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,24314,1410,1.33 [1.16-1.52],4.18262477104659e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,24392,1408,1.77 [1.64-1.90],1.0151844595541322e-52
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,23984,1373,1.47 [1.29-1.69],1.956316127805149e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,23442,1356,1.27 [1.13-1.42],2.5622362712294976e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,21095,1216,1.23 [1.11-1.36],6.11382824969399e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,24200,1394,1.32 [1.16-1.51],3.1813156249112094e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,24249,1400,1.38 [1.17-1.62],9.504657940136456e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,24201,1404,1.51 [1.39-1.64],1.959523415071858e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,24194,1402,1.60 [1.39-1.84],5.172333250550244e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,24314,1410,1.42 [1.25-1.60],3.0177159887582195e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,23703,1359,1.43 [1.28-1.59],1.2456684173523648e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,20595,1191,1.19 [1.09-1.31],7.63670207872447e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,21076,1210,1.47 [1.22-1.77],3.676546686644336e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,21172,1227,1.69 [1.37-2.07],6.055459557413049e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,24101,1383,1.30 [1.16-1.46],8.94404339292848e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,23703,1359,0.68 [0.60-0.77],7.925812406016449e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,24400,1401,1.19 [1.10-1.27],3.019415886034743e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,24088,1399,1.59 [1.35-1.86],2.221971864616392e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,23943,1370,1.22 [1.12-1.32],1.7201908862092887e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,21007,1211,1.24 [1.13-1.36],4.510252788095186e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,24267,1406,0.70 [0.62-0.81],3.975049858751081e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,24205,1401,1.29 [1.19-1.40],1.1710869138932782e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,21010,1209,1.25 [1.16-1.35],8.878138832255775e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,24201,1404,0.70 [0.59-0.82],1.4332070460187316e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,24260,1405,0.54 [0.42-0.68],3.100043443298855e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,24192,1398,1.37 [1.23-1.52],5.828065963132224e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,24101,1383,1.20 [1.14-1.27],6.531503614532425e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,23256,1345,1.12 [1.06-1.18],2.4505731466640743e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,24204,1392,1.79 [1.65-1.93],2.79461125369865e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,24192,1398,1.25 [1.14-1.37],2.610795653531685e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,23699,1374,1.37 [1.24-1.52],1.091373928098487e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,24150,1397,1.17 [1.09-1.27],5.567671849561581e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,24064,1379,1.66 [1.57-1.76],1.1344173749689015e-64
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,24113,1398,1.24 [1.16-1.33],2.0630096169961616e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,24408,1403,1.34 [1.20-1.49],6.522447768140984e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,23739,1376,0.77 [0.71-0.85],5.967997964345205e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,20717,1204,1.25 [1.15-1.36],1.2887988742940853e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,23703,1359,1.23 [1.16-1.31],2.6073013922904597e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,20675,1203,0.66 [0.55-0.79],9.900921117041736e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,24286,1408,1.26 [1.16-1.37],1.1173879217831334e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24272,1406,1.60 [1.34-1.91],1.4958676979195517e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,24267,1406,0.62 [0.52-0.73],2.509005821787473e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,24408,1403,0.66 [0.58-0.74],5.9160297496666976e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,24160,1391,1.72 [1.48-2.00],5.865311162755281e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,23539,1354,1.32 [1.18-1.48],7.252875444745978e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,24272,1406,0.74 [0.66-0.83],1.164436357038691e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,20182,1172,1.64 [1.37-1.97],5.8647005400832283e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,24182,1397,1.28 [1.15-1.43],1.3366318546536903e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,20767,1196,1.91 [1.73-2.11],1.7945258174129252e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,24200,1394,1.57 [1.37-1.80],1.3832348401372103e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,23739,1376,1.12 [1.08-1.17],6.551638256492665e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,24192,1398,1.29 [1.15-1.45],1.8099499365407983e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,21076,1210,1.58 [1.36-1.84],3.583833027004866e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,24408,1403,0.48 [0.39-0.59],7.713641722893944e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24200,1394,1.17 [1.12-1.23],2.7505380238210212e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,24362,1398,1.29 [1.14-1.46],5.284394677391669e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,21095,1216,1.83 [1.63-2.04],3.978275197263694e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,24314,1410,0.69 [0.63-0.76],8.753259625006583e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,24101,1383,0.78 [0.73-0.84],1.0993913137991367e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,21094,1222,2.14 [1.64-2.79],1.8563441646028247e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24243,1405,1.47 [1.28-1.69],8.137700971388529e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,24032,1391,1.18 [1.11-1.26],4.026714761524426e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,24408,1403,1.12 [1.09-1.16],3.3853526418910174e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,23739,1376,1.27 [1.17-1.38],3.4842126814750118e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,21076,1210,1.63 [1.44-1.85],2.089163963368321e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,24143,1396,1.16 [1.08-1.24],6.012149443925189e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20636,1203,1.27 [1.14-1.43],2.194050117424436e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,24485,1416,1.27 [1.13-1.42],8.201669258358604e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20528,1188,1.28 [1.15-1.44],1.2996337548280846e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,21143,1218,1.23 [1.13-1.34],5.616411627365505e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,24435,1413,1.54 [1.34-1.76],7.391173876311331e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,24364,1410,1.24 [1.12-1.37],4.5041173740697256e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,23861,1376,1.28 [1.17-1.39],3.100281195415456e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,23886,1382,2.75 [2.47-3.06],5.965083055459413e-77
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24192,1398,1.56 [1.32-1.85],2.106480824205713e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24192,1398,1.40 [1.24-1.57],2.5820786022763334e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,24200,1394,1.22 [1.11-1.33],1.2048384744168566e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,24272,1406,1.68 [1.41-1.99],3.0738526412747807e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,24436,1409,0.79 [0.71-0.89],5.7059030382000976e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,24408,1411,1.31 [1.20-1.44],1.3772722880688742e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,24049,1398,3.16 [2.66-3.76],3.5982224719565176e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,24392,1413,0.75 [0.67-0.85],5.518945385089545e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24101,1383,1.38 [1.24-1.54],3.3551199290598507e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,21143,1218,0.66 [0.55-0.79],5.788387035265542e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,23739,1376,1.38 [1.21-1.58],2.747051036772509e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,21122,1217,1.65 [1.45-1.89],1.486832385942688e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,24267,1406,1.21 [1.11-1.31],1.2823102442724451e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,24117,1402,1.98 [1.79-2.19],5.386195027754739e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,20922,1209,1.72 [1.51-1.97],2.714344631370929e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,23739,1376,1.25 [1.14-1.37],1.6228781884301564e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,24408,1403,1.33 [1.19-1.49],5.13603796520038e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,20461,1174,1.21 [1.14-1.27],1.690374338988134e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,24308,1407,1.49 [1.36-1.62],4.439048031072699e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,21095,1216,1.61 [1.44-1.80],6.24098578970182e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,24101,1383,1.16 [1.10-1.23],2.55713384325301e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,24101,1383,1.29 [1.20-1.40],1.0811355420543435e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,24032,1391,1.29 [1.18-1.42],3.796757750638201e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,24485,1416,1.22 [1.13-1.33],1.0325700571737804e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,24243,1405,1.33 [1.21-1.46],1.9990088976803947e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,24192,1398,1.70 [1.44-1.99],1.5416450642084203e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,24200,1394,1.26 [1.18-1.34],6.542906821086104e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,24408,1403,0.72 [0.62-0.84],2.0364473046402875e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,21143,1218,1.53 [1.24-1.88],6.607730613334441e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,20988,1209,1.86 [1.61-2.15],2.939897016328918e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,24364,1408,1.51 [1.28-1.78],7.279522602659611e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,20595,1191,1.86 [1.57-2.19],2.4767846952929066e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23618,1368,1.22 [1.14-1.31],2.98142845520788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,24033,1375,1.37 [1.20-1.56],4.567989817206624e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,24400,1401,1.44 [1.23-1.70],9.43041578013932e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,23585,1349,1.66 [1.44-1.92],9.608883551059692e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,24288,1393,1.37 [1.19-1.59],1.980941947791886e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,24237,1405,0.64 [0.61-0.68],2.3730449585159266e-50
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,24271,1407,1.20 [1.15-1.25],4.899241599934832e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,24326,1396,1.30 [1.19-1.42],1.8437304746859925e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,20507,1183,1.35 [1.21-1.50],5.7084510150610016e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,21172,1227,0.59 [0.47-0.74],5.3963534403073664e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,21037,1208,1.45 [1.24-1.69],2.7317899467432617e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,21088,1225,1.97 [1.41-2.73],5.843894301162038e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,24435,1413,1.20 [1.12-1.29],3.4608390797411174e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,21123,1225,1.65 [1.35-2.01],1.0061790990291903e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,23618,1368,1.43 [1.34-1.53],1.709370051326919e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,24200,1394,1.18 [1.10-1.26],3.449435073195568e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,21122,1217,1.91 [1.61-2.26],1.0050061030624633e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,24314,1410,1.25 [1.12-1.39],6.44693936798996e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24200,1394,1.65 [1.41-1.93],7.548613374164057e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,23703,1359,1.30 [1.20-1.41],9.897142102752431e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,23984,1373,1.15 [1.08-1.22],1.5032275603993357e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,20528,1188,0.63 [0.53-0.75],1.400592853638932e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,24400,1401,0.67 [0.60-0.76],1.635953348239994e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,24400,1401,1.37 [1.19-1.58],1.027182111200648e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,24314,1410,1.34 [1.19-1.51],1.6236945593220365e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,24291,1398,1.35 [1.24-1.48],3.5214244462084327e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",24192,1398,1.34 [1.19-1.50],1.1583948728484134e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,23618,1368,1.42 [1.24-1.62],1.7398778022162178e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,24192,1398,1.53 [1.40-1.67],1.884321946025669e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,24143,1396,1.19 [1.11-1.28],5.048453928356954e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,24123,1395,1.73 [1.47-2.03],2.9526553745646545e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,24314,1410,1.26 [1.12-1.41],5.630298577094493e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,24243,1405,1.45 [1.26-1.68],2.65094517931384e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,24081,1385,1.48 [1.30-1.69],2.607643627097987e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24485,1416,1.61 [1.37-1.88],2.934048241607988e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,24143,1396,1.28 [1.20-1.38],2.1796472453247864e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,24192,1398,1.75 [1.57-1.96],7.794361232423927e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,21125,1219,1.39 [1.18-1.63],5.134472353676656e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,21125,1219,1.49 [1.24-1.80],2.7723097021835124e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,24070,1393,1.25 [1.18-1.31],6.067202076235228e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,24271,1407,1.52 [1.42-1.63],6.0488847435728e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,24147,1398,1.31 [1.20-1.42],1.83274936438842e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,24192,1404,1.39 [1.29-1.50],2.4564390060503697e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,24143,1396,1.42 [1.30-1.55],2.1084315260092138e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,24392,1408,1.35 [1.20-1.52],1.1848831142637756e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,24272,1406,1.45 [1.27-1.67],1.244178574047457e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,24192,1398,1.36 [1.21-1.54],7.441384895118267e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,23896,1380,1.72 [1.48-2.01],6.9396997557334266e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,24192,1398,1.24 [1.11-1.39],9.549745423750992e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,24101,1383,1.11 [1.06-1.17],5.104687052084289e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,23703,1373,1.36 [1.25-1.47],7.125407247293008e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24033,1375,1.95 [1.73-2.20],3.914848764192059e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24033,1375,1.83 [1.77-1.88],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24435,1413,1.38 [1.23-1.55],4.3325815464936144e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24201,1404,1.37 [1.18-1.59],4.278595550109084e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24272,1406,1.81 [1.60-2.05],1.6810380255587182e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24243,1405,1.69 [1.46-1.96],3.715444752842153e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24192,1398,1.82 [1.57-2.12],2.8888692083031626e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24192,1398,1.58 [1.47-1.68],7.361229438004342e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24392,1408,1.33 [1.18-1.50],2.0762730776083352e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24033,1375,1.47 [1.37-1.58],3.144932205658965e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24033,1375,1.32 [1.17-1.48],3.0316148620671293e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24143,1396,0.85 [0.79-0.92],4.444457530745255e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24314,1410,1.62 [1.37-1.92],3.0477948776529386e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24443,1415,1.57 [1.34-1.83],1.0985614285002742e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,24033,1375,0.69 [0.62-0.77],1.001074124187436e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,24045,1394,1.49 [1.38-1.60],7.616813034549256e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,24201,1404,1.69 [1.55-1.83],1.0204887229723368e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,24033,1375,1.43 [1.26-1.61],1.090663047957219e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,24411,1409,0.77 [0.71-0.84],8.620626725002611e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,24354,1408,1.24 [1.15-1.33],1.8850490128521564e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,21007,1211,1.47 [1.34-1.60],6.066064291309193e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,24162,1396,1.51 [1.34-1.69],4.827509925622754e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,24361,1398,1.54 [1.39-1.71],5.901429847828957e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,23943,1369,1.33 [1.18-1.50],4.062139361577216e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,24365,1400,1.15 [1.07-1.24],8.219718047976294e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,22947,1323,2.56 [2.34-2.81],1.8179306868103188e-91
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",23954,1366,0.70 [0.62-0.78],3.7098014371358646e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,21076,1210,1.66 [1.36-2.01],3.542186547614791e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,23739,1376,1.22 [1.11-1.34],5.565503691134362e-05
